These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33712566)

  • 1. JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.
    Le K; Wellik LE; Maurer MJ; McPhail ED; Witzig TE; Gupta M
    Blood Cancer J; 2021 Mar; 11(3):56. PubMed ID: 33712566
    [No Abstract]   [Full Text] [Related]  

  • 2. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
    Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma.
    Rajan SS; Amin AD; Li L; Rolland DC; Li H; Kwon D; Kweh MF; Arumov A; Roberts ER; Yan A; Basrur V; Elenitoba-Johnson KSJ; Chen XS; Puvvada SD; Lussier YA; Bilbao D; Lim MS; Schatz JH
    Oncogene; 2020 Mar; 39(10):2103-2117. PubMed ID: 31804622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK
    Fragliasso V; Verma A; Manzotti G; Tameni A; Bareja R; Heavican TB; Iqbal J; Wang R; Fiore D; Mularoni V; Chan WC; Lhoumaud P; Skok J; Zanetti E; Merli F; Ciarrocchi A; Elemento O; Inghirami G
    Leukemia; 2020 Nov; 34(11):2964-2980. PubMed ID: 32123306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement.
    Khanlari M; Tang G; Hao S; Gong Y; Li S; Miranda RN; Lin P; Iyer S; Yin CC; Xie W; Vega F; Medeiros LJ; Xu J
    Br J Haematol; 2021 Jan; 192(1):e17-e21. PubMed ID: 33216956
    [No Abstract]   [Full Text] [Related]  

  • 6. β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Anand M; Lai R; Gelebart P
    Haematologica; 2011 Feb; 96(2):253-61. PubMed ID: 20971814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.
    Hoareau-Aveilla C; Quelen C; Congras A; Caillet N; Labourdette D; Dozier C; Brousset P; Lamant L; Meggetto F
    Haematologica; 2019 Feb; 104(2):347-359. PubMed ID: 30262555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.
    Prutsch N; He S; Berezovskaya A; Durbin AD; Dharia NV; Maher KA; Matthews JD; Hare L; Turner SD; Stegmaier K; Kenner L; Merkel O; Look AT; Abraham BJ; Zimmerman MW
    Cell Rep Med; 2024 Mar; 5(3):101472. PubMed ID: 38508140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long Non-Coding RNA MIR503HG Enhances Proliferation of Human ALK-Negative Anaplastic Large-Cell Lymphoma.
    Huang PS; Chung IH; Lin YH; Lin TK; Chen WJ; Lin KH
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29758012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
    Jaye DL; Feldman AL
    Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
    [No Abstract]   [Full Text] [Related]  

  • 11. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.
    Ding H; Liu J; Liu B; Zeng Y; Chen P; Su Y
    Biochem Biophys Res Commun; 2018 Jun; 500(4):973-980. PubMed ID: 29715456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.
    Lollies A; Hartmann S; Schneider M; Bracht T; Weiß AL; Arnolds J; Klein-Hitpass L; Sitek B; Hansmann ML; Küppers R; Weniger MA
    Leukemia; 2018 Jan; 32(1):92-101. PubMed ID: 28659618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemic presentation of a highly aggressive ALK-negative anaplastic large cell lymphoma.
    Xu D; Naresh KN
    Blood; 2021 Sep; 138(13):1198. PubMed ID: 34591095
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
    Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
    BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Coding RNA Networks in ALK-Positive Anaplastic-Large Cell Lymphoma.
    Fuchs S; Naderi J; Meggetto F
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.
    Pearson JD; Lee JK; Bacani JT; Lai R; Ingham RJ
    Int J Clin Exp Pathol; 2011 Jan; 4(2):124-33. PubMed ID: 21326808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma.
    Spaccarotella E; Pellegrino E; Ferracin M; Ferreri C; Cuccuru G; Liu C; Iqbal J; Cantarella D; Taulli R; Provero P; Di Cunto F; Medico E; Negrini M; Chan WC; Inghirami G; Piva R
    Haematologica; 2014 Jan; 99(1):116-24. PubMed ID: 23975180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of C/EBPβ target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation.
    Bonzheim I; Irmler M; Klier-Richter M; Steinhilber J; Anastasov N; Schäfer S; Adam P; Beckers J; Raffeld M; Fend F; Quintanilla-Martinez L
    PLoS One; 2013; 8(5):e64544. PubMed ID: 23741337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel model of controlling PD-L1 expression in ALK
    Zhang JP; Song Z; Wang HB; Lang L; Yang YZ; Xiao W; Webster DE; Wei W; Barta SK; Kadin ME; Staudt LM; Nakagawa M; Yang Y
    Blood; 2019 Jul; 134(2):171-185. PubMed ID: 31151983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
    BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.